Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain

NCT06379165 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Meloxicam Nanocrystal Injection
DRUG: Placebo

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.